MDLN
Medline Inc.
Stock
$35.61+0.67 (+1.92%)Close Oct 2, 2026
Cash flow statement
| Line | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | $1.7B | $1.8B | $1.7B |
| Capital expenditures | $447M | $354M | $275M |
| Free cash flow | $1.3B | $1.4B | $1.4B |
| Stock-based compensation | $76M | $61M | $78M |
| Buybacks | $33M | $20M | $0 |
| Free cash flow margin | 4.6% | 5.5% | 6.1% |